Justice Department, Antitrust Division
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Justice Antitrust Division ( printed page 52097) Notice is hereby given that, on April 12, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), Biopharmaceutical Manufacturing Preparedness Consortium (“BIOMAP-CONSORTIUM”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, A-line, Inc., Signal Hill, CA; API Innovation Center, St. Louis, MO; AVS Bio, Norwich, CT; Advanced Concept Innovations, Lakeland, FL; Afton Scientific, Charlottesville, VA; Alchem Laboratories Corp., Alachua, FL; AmerStem, Inc., Camarillo, CA; American Medicines Company, PBC, Davisville, WV; American Type Culture Collection, Manassas, VA; Amyris, Inc., Emeryville, CA; AntoXa Corp., Toronto, CANADA; Apertus Pharmaceuticals LLC, Ballwin, MO; Argonaut Manufacturing Services, Inc., Carlsbad, CA; Asha Therapeutics LLC, Tampa, FL; Attogene Corp., Austin, TX; BASF Corp., Florham Park, NJ; BCG Federal Corp., Washington, DC; BDO Public Sector LLC, McLean, VA; Batavia Biosciences, Inc., Woburn, MA; Benuvia Operations LLC, Round Rock, TX; Bionova Scientific LLC, Fremont, CA; Biosortia Pharmaceuticals, Inc., Dublin, OH; Black Me…
Citation: 89 FR 52097
